VistaGen Share Price

VistaGen Share Price

NASDAQ: VTGN | Micro Cap | Healthcare
$0.19
+$0.01 (6.93%) Last updated on 19 Nov, 2026 | 01:24 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

VistaGen Stock Performance

Open
$0.20
Prev. Close
$0.18
Circuit Range
N/A
Day Range
$0.19 - $0.20
Year Range
$0.17 - $5.14
Volume
8,716
Average Traded
$0.20

VistaGen Share Price Today

As of 19 November 2026, VistaGen Therapeutics, Inc.'s share price is $0.19. The stock opened at $0.20, compared to its previous close of $0.18. During today's trading session, VistaGen Therapeutics, Inc.'s share price traded between $0.19 and $0.20, with an average price of $0.20. Over the past 52 weeks, the stock has recorded a high of $5.14 and a low of $0.17. In terms of performance, VistaGen Therapeutics, Inc.'s share price has declined by 69.34% over the last six months and is down 96.02% on a year-on-year basis.

VistaGen Share Price Chart

Line chart of the VistaGen price trend over the selected period. The price rose overall, ranging from 0.19 to 0.20, ending at 0.19.
$0.19$0.20
L
Show Current Price
H

VistaGen Stock Fundamentals & Key Indicators

Market Cap
$6.00M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.46
Revenue (TTM)
$1.27B
Return On Equity (TTM)
-276.16%
Profit Margin
-5487.40%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
32.84%

VistaGen Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.26$0.30$0.47$1.48
Net Profit-$19.40-$18.90-$16.27-$13.03
Net Profit Margin-7461.54%-6300.00%-3461.70%-880.41%
Income ChangeN/A2.58%13.92%19.91%

VistaGen Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue-$0.23$1.06$0.49$1.27
Net Profit-$59.25-$29.36-$51.42-$69.69
Net Profit Margin25760.87%-2769.81%-10493.88%-5487.40%
Income ChangeN/A50.45%-75.14%-35.53%

VistaGen Balance Sheet

All figures in USD Million

Particulars2026202520242023
Non Current Assets1.622.272.983.58
Current Assets46.9482.08120.6717.51
Total Assets48.5684.34123.6521.09
Non Current Liabilities0.251.344.244.44
Current Liabilities12.812.615.124.57
Total Liabilities13.0413.959.379.01
Shareholders' Equity35.5270.39114.2912.08

VistaGen Cash Flow

Annually

All figures in USD Million

Particulars2026202520242023
Operating-66.44-42.1-25.81-49.72
Investing-0.88-13.15-0.06-0.74
Financing30.973.21128.4-1.04

Corporate Actions

Split
Ex-date: 07 Jun 2023

About VistaGen

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

VistaGen Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.17
$0.19
+15.48%
Oct 2026
$0.31
$0.17
-44.92%
Sep 2026
$0.24
$0.30
+20.55%
Aug 2026
$0.25
$0.25
+3.69%
Jul 2026
$0.22
$0.24
+8.93%
Jun 2026
$0.63
$0.22
-64.67%
May 2026
$0.63
$0.63
+3.43%
Apr 2026
$0.60
$0.61
+5.33%
Mar 2026
$0.57
$0.58
-0.51%
Feb 2026
$0.58
$0.58
+5.22%
Jan 2026
$0.65
$0.56
-16.14%
Dec 2025
$4.78
$0.66
-86.43%

VistaGen Share Price FAQs